EU Checks Pharma’s Appetite To Share Market Launch Intentions
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
Ambitious efforts to make the EU more resilient to future challenges, such as health threats, drug supply problems, scientific advances and growing medicine costs, have taken a step forward with the publication of a roadmap for a wide-ranging Pharmaceutical Strategy to be adopted by the European Commission later in the year.
The UK has started monitoring whether clinical trial sponsors are fulfilling responsibilities to make their research open and transparent.